Prices delayed by at least 15 minutes | Print
Inchcape PLC (INCH)
ORD 10PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
LONDON BROKER RATINGS: Berkeley and Advanced Medical Solutions raised
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
----------
FTSE 100
----------
UBS raises Berkeley Group Holdings to 'buy' (neutral) - price target 4,965 (5,385) pence
----------
Peel Hunt raises Antofagasta to 'add' (hold) - price target 1,860 (1,825) pence
----------
Citigroup cuts HSBC price target to 990 (1,070) pence - 'buy'
----------
Citigroup cuts Standard Chartered price target to 1,115 (1,250) pence - 'neutral'
----------
HSBC cuts AstraZeneca price target to 12,000 (13,720) pence - 'buy'
----------
Deutsche Bank Research raises BAE Systems price target to 1,900 (1,510) pence - 'buy'
----------
Goldman Sachs cuts Centrica price target to 186 (187) pence - 'buy'
----------
Goldman Sachs cuts WPP price target to 649 (655) pence - 'neutral'
----------
Barclays cuts WPP price target to 700 (780) pence - 'equal weight'
----------
UBS cuts WPP price target to 520 (580) pence - 'sell'
----------
UBS cuts Diageo price target to 2,650 (2,920) pence - 'buy'
----------
Jefferies cuts Diageo price target to 2,500 (2,800) pence - 'buy'
----------
JPMorgan raises Fresnillo price target to 1,450 (1,000) pence - 'overweight'
----------
Jefferies raises Coca-Cola HBC price target to 4,400 (3,750) pence - 'buy'
----------
Jefferies cuts St James's Place price target to 1,160 (1,266) pence - 'buy'
----------
Jefferies cuts Unilever price target to 3,600 (3,700) pence - 'underperform'
----------
FTSE 250
----------
Exane BNP cuts Inchcape to 'neutral' (outperform) - price target 725 (975) pence
----------
Deutsche Bank Research starts Sirius Real Estate with 'buy' - price target 110 pence
----------
RBC starts Qinetiq with 'sector perform' - price target 450 pence
----------
RBC starts Chemring with 'outperform' - price target 500 pence
----------
UBS cuts Victrex price target to 780 (1000) pence - 'sell'
----------
JPMorgan cuts Man Group to 'neutral' (overweight) - price target 167 (242) pence
----------
Morgan Stanley cuts Burberry price target to 825 (1,125) pence - 'equal-weight'
----------
RBC cuts Asos price target to 400 (450) pence - 'sector perform'
----------
RBC cuts PageGroup price target to 385 (445) pence - 'outperform'
----------
RBC cuts Hays price target to 100 (105) pence - 'outperform'
----------
JPMorgan raises Hochschild Mining target to 430 (300) pence - 'overweight'
----------
SMALL CAP
----------
Stifel raises Advanced Medical Solutions to 'buy' (hold) - price target 245 pence
----------
RBC starts Cohort with 'outperform' - price target 1,570 pence
----------
RBC cuts Ceres Power price target to 90 (110) pence - 'sector perform'
----------
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.